Treace Medical Concepts I... (TMCI)
Treace Medical Concepts Statistics
Share Statistics
Treace Medical Concepts has 62.62M shares outstanding. The number of shares has increased by 0.98% in one year.
Shares Outstanding | 62.62M |
Shares Change (YoY) | 0.98% |
Shares Change (QoQ) | 0.52% |
Owned by Institutions (%) | 59.93% |
Shares Floating | 44.91M |
Failed to Deliver (FTD) Shares | 21 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.27M, so 3.64% of the outstanding shares have been sold short.
Short Interest | 2.27M |
Short % of Shares Out | 3.64% |
Short % of Float | 5% |
Short Ratio (days to cover) | 7.98 |
Valuation Ratios
The PE ratio is -8.29 and the forward PE ratio is -13.53. Treace Medical Concepts's PEG ratio is -0.75.
PE Ratio | -8.29 |
Forward PE | -13.53 |
PS Ratio | 2.21 |
Forward PS | 1.6 |
PB Ratio | 4.09 |
P/FCF Ratio | -9.48 |
PEG Ratio | -0.75 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Treace Medical Concepts.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.
Current Ratio | 4.62 |
Quick Ratio | 3.5 |
Debt / Equity | 0.62 |
Debt / EBITDA | -1.66 |
Debt / FCF | -1.43 |
Interest Coverage | -10.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $438.9K |
Profits Per Employee | $-116.86K |
Employee Count | 477 |
Asset Turnover | 0.96 |
Inventory Turnover | 1.05 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -32.14% in the last 52 weeks. The beta is 0.78, so Treace Medical Concepts's price volatility has been higher than the market average.
Beta | 0.78 |
52-Week Price Change | -32.14% |
50-Day Moving Average | 9.17 |
200-Day Moving Average | 7.28 |
Relative Strength Index (RSI) | 44.78 |
Average Volume (20 Days) | 407.21K |
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 209.36M and earned -55.74M in profits. Earnings per share was -0.9.
Revenue | 209.36M |
Gross Profit | 168.26M |
Operating Income | -55.69M |
Net Income | -55.74M |
EBITDA | -42.07M |
EBIT | -50.49M |
Earnings Per Share (EPS) | -0.9 |
Balance Sheet
The company has 11.35M in cash and 69.65M in debt, giving a net cash position of -58.3M.
Cash & Cash Equivalents | 11.35M |
Total Debt | 69.65M |
Net Cash | -58.3M |
Retained Earnings | -189.99M |
Total Assets | 217.09M |
Working Capital | 126.48M |
Cash Flow
In the last 12 months, operating cash flow was -37.17M and capital expenditures -11.59M, giving a free cash flow of -48.76M.
Operating Cash Flow | -37.17M |
Capital Expenditures | -11.59M |
Free Cash Flow | -48.76M |
FCF Per Share | -0.79 |
Margins
Gross margin is 80.37%, with operating and profit margins of -26.6% and -26.63%.
Gross Margin | 80.37% |
Operating Margin | -26.6% |
Pretax Margin | -26.63% |
Profit Margin | -26.63% |
EBITDA Margin | -20.09% |
EBIT Margin | -26.6% |
FCF Margin | -23.29% |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for TMCI is $8, which is -3.8% lower than the current price. The consensus rating is "Hold".
Price Target | $8 |
Price Target Difference | -3.8% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Scores
Altman Z-Score | 2.7 |
Piotroski F-Score | 3 |